Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Latitude-An Observational Study of Patient Choice and the Urethral Bulking Agent, Bulkamid®, Used for the First Line Treatment for Stress Urinary Incontinence and the Impact on a Subsequent Mid Urethral Sling

NCT03474653 is registered in ClinicalTrials.gov with Manchester University NHS Foundation Trust as lead sponsor.

NCT NCT03474653
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03474653 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Latitude-An Observational Study of Patient Choice and the Urethral Bulking Agent, Bulkamid®, Used for the First Line Treatment for Stress Urinary Incontinence and the Impact on a Subsequent Mid Urethral Sling
Lead sponsor
Manchester University NHS Foundation Trust
Phase
Observational
Overall status
Unknown status
Start date
June 12, 2017
Completion date
June 30, 2024
Enrollment
399 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stress urinary incontinence, urinary incontinence